Dr. Costin on Frontline Immunotherapy for Patients With NSCLC – OncLive
OncLive |
Dr. Costin on Frontline Immunotherapy for Patients With NSCLC
OncLive Daniel Costin, MD, hematology and oncology, White Plains Hospital, discusses the potential with immunotherapy agents in the frontline setting as treatment for patients with non–small cell lung cancer (NSCLC). Immunotherapy has become a standard of care … |
